Investor Relations
Welcome to Alzinova AB’s IR pages.
Alzinova AB is a company specializing in the treatment of Alzheimer’s disease – one of our major health scourges, without effective treatment options.
Latest news
- 2026-09-11 DNB Carnegie: ALZ-101 enters Phase II start-up as Alzinova raises capital
- 2026-09-11 Redeye: Phase II study update and SEK51 rights issue
